In case you missed it: August 8 to August 12
A look back at the week's top stories.
Vivjoa approved for recurrent vulvovaginal candidiasis
Oteseconazole is a treatment option for those living with a previously unmet medical need.
Essentials of vulvovaginal dermatology
Correct terms and education can help normalize the conversation for patients.
Neighborhood disadvantage and fertility rates
Residing in a socioeconomically disadvantaged neighborhood was linked to moderately decreased fecundability, according to a study published in JAMA Network Open.
Maternal mortality before and during COVID pandemic
Maternal deaths in the United States rose by a staggering 33% after the onset of the COVID-19 pandemic in March 2020, which is a significantly higher percentage than the 22% overall excess death estimate linked to the pandemic, according to a research letter published in JAMA Network Open.
Monkeypox vaccine gets emergency approval to increase vaccine supply
Smaller dose given by intradermal injection creates five-fold increase in total supply, FDA says.
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
